- Published on
Research finds 485 chemicals in US pesticide products linked to breast cancer
- Authors
- Name
- DeepHorus
A peer-reviewed review has identified at least 485 chemicals used in U.S. pesticide products that have been linked to breast cancer, widening scrutiny of agricultural chemicals, household pest treatments, and products applied directly to children. The paper appeared in Environmental Health Perspectives, the American Chemical Society’s environmental health journal. Researchers from the Silent Spring Institute say the findings highlight shortcomings in federal regulation rather than prove that every listed chemical causes breast cancer at every exposure. Even so, the researchers argue that the scale and variety of potential exposures demand a more comprehensive assessment.
Breast cancer is the most commonly diagnosed cancer in the United States, aside from skin cancer, and rates have been rising. According to the American Cancer Society, incidence increased by about 1% annually, with growth among women younger than 50 reaching 1.4% per year. Pesticide use has also increased in recent years, making it harder to separate changing exposure patterns from other possible contributors to early-onset disease. The new review does not establish that pesticides explain the increase, but it raises questions about whether regulators are adequately tracking chemicals capable of affecting hormonal and reproductive systems.
The analysis covered both active pesticide ingredients and so-called inert ingredients included in formulations. The chemicals are not limited to crop pesticides; they can also appear in home lawn products, lice treatments applied to children’s scalps, and flea and tick controls. Some inactive substances serve as solvents, surfactants, or penetrating agents that improve dispersal and absorption. Although they do not directly target pests, these chemicals may remain biologically active in people and other non-target organisms.
A central concern is that the Environmental Protection Agency evaluates individual ingredients but generally does not assess the complete pesticide formula or cumulative exposure to multiple chemicals. That approach can miss interactions among compounds, as well as risks created when several products are used repeatedly or applied near one another. It may also understate vulnerable populations, including children, pregnant people, agricultural workers, and communities living near treated fields. The researchers say “inert” should not be interpreted as harmless, because the human body can absorb inactive ingredients just as it absorbs active ones.
Federal data illustrate the reach of the issue: the National Health and Nutrition Examination Survey detected 84 of the breast cancer-linked chemicals reviewed by the institute in the general population. Scientists describe that figure as a substantial undercount because the survey does not monitor most of the other compounds identified in the report. The institute’s wider work has also found roughly 500 such chemicals in common consumer goods and 462 in drinking water. These results point to a wider web of exposure that cannot be understood through regulation of crop chemicals alone.
Public health advocates have long argued that the approximately 4,000 inert ingredients approved by the EPA receive insufficient safety review. The category has included per- and polyfluoroalkyl substances, commonly known as PFAS or “forever chemicals,” which can persist in the environment and the human body. The institute also questions the agency’s treatment of non-monotonic dose responses, in which some hormone-disrupting chemicals may have effects at low exposure levels but not at higher doses. In 2023, the EPA rejected a legal petition seeking more stringent review of inactive ingredients, reinforcing what researchers characterize as a regulatory blind spot.
Reaction to the findings has focused on possible conflicts of interest within the EPA. Silent Spring Institute co-author Jenny Kay said industry pressure and the movement of personnel between regulators and chemical companies may influence scientific evaluations. She called cumulative exposure “pretty consequential and concerning” and said the review was intended to draw attention to pesticides used in many everyday settings. The EPA’s response to the new paper was not detailed in the supplied material, while the findings are likely to add pressure for disclosure of full product ingredients and independent testing of previously approved compounds.
In the near term, the institute is calling for an expansion of California’s Proposition 65, which requires warnings for chemicals known to cause cancer or reproductive harm. Broader change could require the EPA to evaluate whole formulations, measure low-dose and cumulative effects, and reduce reliance on inert-designation loopholes. Researchers are not calling for every listed chemical to be banned outright; instead, they want risk assessment to reflect realistic exposure and the latest evidence. If regulators respond, the debate could reshape pesticide approvals and influence product labeling across agriculture, veterinary care, and household pest control.
